Things I compiled yesterday as part of my stock research activities.
Key Quarterly Results
Key Updates
🟢 Balaji Amines commences commercial production at its 1,00,000 TPA Dimethyl Ether plant in Solapur, becoming India’s first DME manufacturer. BIS has approved 20% DME blending with LPG, and this capacity is estimated to add approximately 15% to current annual revenues.
🟢 Eris Lifescience guides FY27 revenue growth at 18% to 20%. This is well ahead of India’s pharma industry average of 9 to 10%, driven by chronic therapy launches and integration gains from the Biocon Biologics asset acquisition.
🟢 Star Health targets ₹24,000 Cr in gross written premium for FY27 with 65% sourced from smaller cities, and launches its ‘Value Plus’ health plan. Tier-2 and tier-3 health insurance penetration is currently growing at over twice the metro rate, supporting this geographic pivot.
🟢 Mankind Pharma guides for double-digit top-line growth and EBITDA margins of 25.5% to 26.5% in FY27. The margin band is among the strongest in mid-cap pharma, reflecting Mankind’s acute therapy dominance and low-cost domestic manufacturing base.
🟢 Shaily Engineering Plastics receives regulatory approval and launches a combination drug product incorporating its ShailyPen Neo device technology. The wearable drug delivery segment is a high-barrier, high-value niche with growing global pharma outsourcing potential for contract device manufacturers.
🟢 HDFC Bank approves 2-day work-from-home for business and corporate functions. India’s largest private bank normalizing hybrid work is a bellwether signal for the financial services sector, where return-to-office mandates have been stricter than in other industries.
🟢 Pace Digitek wins a ₹264.65 Cr contract from BSNL to design, build, and maintain the BharatNet Middle Mile Network in the Sikkim Telecom Circle over 1,095 days. BharatNet 3.0 carries a ₹1.39 lakh crore national outlay, giving Pace Digitek multi-year recurring revenue visibility.
🔴 The Gold Jewellery Association reports sharp demand distress, with buyer footfall declining significantly over the last 10 days.
🔴 Bollywood workers face pay cuts of 50 to 60% as fewer movie and OTT projects receive approval. A string of box office failures and tighter OTT content budgets have sharply reduced production activity across the entertainment sector.
🔴 Indonesia announces curbs on palm oil commodity exports. India imports approximately 60% of its palm oil from Indonesia, and supply restrictions are likely to push edible oil prices higher in the near term.
🟢 NCDEX launches weather derivatives on Mumbai rain, making it India’s first standardized weather derivative contract. This creates a new asset class for hedging rainfall-linked business risk across agriculture, infrastructure, and event-dependent industries.
That’s it for today.
FINVEZTO.COM | Flexi-Wealth System. One-Wealth Building System. For Life.
Disclaimer: Anand Ganapathy K is a SEBI-registered Research Analyst with SEBI registration number INH000016630. This post is purely for learning purposes. We do not recommend buying or selling stocks mentioned in this newsletter. Securities market investments carry market risks. Kindly review all related documents before investing.